Labcorp Return on Tangible Equity 2010-2024 | LH

Current and historical return on tangible equity values for Labcorp (LH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Labcorp Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $0.44B $-1.85B -26.12%
2024-06-30 $0.45B $-1.55B -27.45%
2024-03-31 $0.43B $-1.65B -31.22%
2023-12-31 $0.42B $-1.61B -29.95%
2023-09-30 $0.66B $-1.73B -84.66%
2023-06-30 $0.83B $-0.55B -100.06%
2023-03-31 $1.00B $-1.69B -92.07%
2022-12-31 $1.28B $0.85B -125.52%
2022-09-30 $1.76B $-1.93B -110.69%
2022-06-30 $1.99B $-1.58B -143.42%
2022-03-31 $2.10B $-1.42B -160.60%
2021-12-31 $2.38B $-1.42B -177.92%
2021-09-30 $2.76B $-1.14B -178.22%
2021-06-30 $2.88B $-1.25B -137.75%
2021-03-31 $2.64B $-1.53B -95.67%
2020-12-31 $1.56B $-2.28B -45.13%
2020-09-30 $0.85B $-3.30B -21.33%
2020-06-30 $0.36B $-3.95B -8.46%
2020-03-31 $0.32B $-4.27B -7.16%
2019-12-31 $0.82B $-4.33B -18.50%
2019-09-30 $0.76B $-4.61B -16.99%
2019-06-30 $0.85B $-4.72B -19.75%
2019-03-31 $0.90B $-4.16B -21.11%
2018-12-31 $0.88B $-4.30B -19.90%
2018-09-30 $1.41B $-4.11B -31.02%
2018-06-30 $1.27B $-4.44B -25.67%
2018-03-31 $1.22B $-4.93B -24.74%
2017-12-31 $1.23B $-4.76B -25.74%
2017-09-30 $0.70B $-5.62B -15.11%
2017-06-30 $0.71B $-4.39B -16.42%
2017-03-31 $0.73B $-4.32B -16.97%
2016-12-31 $0.71B $-4.32B -16.37%
2016-09-30 $0.66B $-4.32B -14.90%
2016-06-30 $0.63B $-4.26B -14.02%
2016-03-31 $0.60B $-4.50B -12.74%
2015-12-31 $0.44B $-4.58B -8.90%
2015-09-30 $0.45B $-4.72B -10.63%
2015-06-30 $0.43B $-5.01B -12.36%
2015-03-31 $0.40B $-5.37B -14.76%
2014-12-31 $0.51B $-1.76B -26.88%
2014-09-30 $0.52B $-1.79B -26.01%
2014-06-30 $0.53B $-1.96B -25.77%
2014-03-31 $0.54B $-2.10B -26.41%
2013-12-31 $0.57B $-2.10B -29.30%
2013-09-30 $0.57B $-2.03B -29.96%
2013-06-30 $0.57B $-1.93B -30.75%
2013-03-31 $0.57B $-1.76B -32.01%
2012-12-31 $0.58B $-1.85B -33.15%
2012-09-30 $0.60B $-1.83B -34.26%
2012-06-30 $0.58B $-1.65B -34.15%
2012-03-31 $0.55B $-1.70B -31.98%
2011-12-31 $0.52B $-1.80B -29.16%
2011-09-30 $0.52B $-1.69B -28.95%
2011-06-30 $0.52B $-1.74B -31.70%
2011-03-31 $0.55B $-1.89B -36.82%
2010-12-31 $0.56B $-1.81B -42.56%
2010-09-30 $0.57B $-1.15B -49.80%
2010-06-30 $0.56B $-1.16B -48.79%
2010-03-31 $0.54B $-1.14B -48.94%
2009-12-31 $0.54B $-1.13B -48.69%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.603B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95